It is a trading private limited company based in New Delhi, Delhi, India, established in 2002.
2002 | New Delhi, Delhi, India | ActiveNew Horizon Pharmatech Private Limited, a active private limited company, was established on 06 August 2002 in New Delhi, Delhi, India. Engaging in other wholesale within the trade sector, it holds CIN: U22122DL2002PTC116463. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.15 M.
It upholds a compliant status. Its leadership includes Nirmala Kumari (Director), Neelam Kumari (Director). Past directors included Vinit Kumar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at K-28, T/F South Extension Part Ii, New Delhi, Delhi, 110049.
U22122DL2002PTC116463
116463
06 August 2002
₹1.00 M
₹0.15 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into New Horizon Pharmatech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nirmala Kumari | Director | 06 Aug 2002 | Current |
| Neelam Kumari | Director | 06 Aug 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Sep 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
New Horizon Pharmatech Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 61.67% decrease. The company also saw a substantial fall in profitability, with a 293.42% decrease in profit. The company's net worth observed a substantial decline by a decrease of 34.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, New Horizon Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with New Horizon Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of New Horizon Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Horizon Pharmatech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity New Horizon Pharmatech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on New Horizon Pharmatech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on Nirmala Kumari was appointed as a Director was appointed as a Director on 06 Aug 2002 & has been associated with this company since 23 years 4 months . was documented.
The activity Neelam Kumari was appointed as a Director was appointed as a Director on 06 Aug 2002 & has been associated with this company since 23 years 4 months . was completed.
New Horizon Pharmatech Private Limited was registered on 06 Aug 2002 with Roc Delhi & aged 23 years 4 months as per MCA records. was recorded as a recent event.
The CIN of New Horizon Pharmatech Private Limited is U22122DL2002PTC116463.
New Horizon Pharmatech Private Limited is headquartered at K-28, T/F South Extension Part Ii, New Delhi, Delhi, 110049.
New Horizon Pharmatech Private Limited was incorporated on 06 August 2002.
The current directors of New Horizon Pharmatech Private Limited are
The primary industry of New Horizon Pharmatech Private Limited is Trade.
New Horizon Pharmatech Private Limited is unlisted.
The authorized capital of New Horizon Pharmatech Private Limited is ₹1.00 M, and the paid-up capital is ₹0.15 M.
The compliance status of New Horizon Pharmatech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX